Identifying factors to prevent early stillbirths

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify modifiable risk factors linked to stillbirths occurring between 20 and 28 weeks of pregnancy. By comparing bereaved mothers who experienced stillbirth with pregnant women at the same gestation, the study seeks to explore behavioral and healthcare-related factors that could be adjusted to reduce early stillbirth rates. The research will also investigate the interactions between maternal characteristics and fetal factors to better understand their impact on early stillbirth risk. The findings could inform public health campaigns and antenatal care practices to help achieve the UK government's goal of reducing stillbirths by 50% by 2025.

Why it matters

Who can join: the full rules

Cases

* Bereaved mothers/parents who have recently birthed a singleton baby who died before/during or immediately after labour between 20 and 28 weeks of pregnancy.
* Baby has no evidence of congenital anomaly
* Able to give written informed consent

Controls

* Pregnant women/people with an ongoing pregnancy (at the target gestation) receiving antenatal care from a participating maternity unit, at a gestation matched to the distribution of stillbirths between 20 to 28 weeks of pregnancy in the same unit
* Baby has no evidence of congenital anomaly
* Able to give written informed consent

Where it's running

• Manchester University NHS Foundation Trust
  Manchester, United Kingdom Recruiting

Study contacts

• Study coordinator: Alexander E Heazell, PhD
• Email: alexander.heazell@manchester.ac.uk
• Phone: +441612646484

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Amnioinfusion to Protect Newborns After Meconium in Amniotic Fluid

  This trial tests whether a structured lactated Ringer's amnioinfusion during labor can reduce breathing problems and related complications in babies whose amniotic fluid contains meconium.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT07274527

• Improving intrapartum care in Ethiopia to reduce stillbirths and maternal deaths

  This study is testing a new approach to improve care during childbirth in Ethiopia to see if it can help reduce stillbirths and keep mothers safer.

  Recruiting Haramaya Unversity · Harar, Oromiya and 1 other locations · NCT06273007

• Using melatonin to protect the brain in pregnancies with fetal growth restriction

  This study is testing if giving melatonin to pregnant women with severe fetal growth restriction can help improve their baby's health and protect against brain injury before birth.

  Recruiting at 12 sites Phase 3 Monash University · Camperdown, New South Wales and 11 other locations · NCT05651347

• Two-way SMS support for newborn care with community health volunteers in Western Kenya

  This project will test whether daily automated and interactive SMS messages linking new mothers to community health volunteers can help mothers spot newborn danger signs and get timely help in Western Kenya.

  Recruiting University of Washington · Kisumu · NCT05187897

• Screening and planned delivery to prevent preeclampsia at term

  This study is testing a new blood test to see if it can help predict preeclampsia in first-time pregnant women and if inducing labor early can lower the chances of complications for both mom and baby.

  Recruiting at 8 sites Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Liège and 20 other locations · NCT04766866

• Using aspirin to prevent complications in pregnant women with chronic hypertension

  This study is testing whether taking low-dose aspirin during pregnancy can help prevent serious complications for women with chronic high blood pressure and their babies.

  Recruiting at 14 sites Phase 3 Centre Hospitalier Intercommunal Creteil · Bordeaux and 19 other locations · NCT04356326

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.